Bayban’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.33K Hold
10
– – ﹤0.01% 472
2026
Q2
$2.12K Hold
10
– – ﹤0.01% 530
2026
Q1
$1.96K Hold
10
– – ﹤0.01% 567
2025
Q4
$1.74K Buy
+10
New +$1.82K ﹤0.01% 551

Other funds holding DGX

Bayban's DGX Position: Q3 2026 in Review

Bayban held its Quest Diagnostics (DGX) position steady in Q3 2026 at 10 shares worth $2.33K. The position accounts for ﹤0.01% of the portfolio, ranked #472.

Bayban first reported a position in DGX in Q4 2025 and has held it in 4 quarters since. 1,142 funds tracked by Wall St. Rank hold DGX as of Q3 2026.

  • Bayban held 10 shares of Quest Diagnostics worth $2.33K as of Q3 2026.
  • Bayban left its Quest Diagnostics share count unchanged in Q3 2026.
  • Quest Diagnostics made up ﹤0.01% of Bayban's portfolio in Q3 2026, its #472 holding.
  • Bayban first reported a position in Quest Diagnostics in Q4 2025 and has held it in 4 quarters since.
  • 1,142 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.

Based on Bayban's 13F filing for Q3 2026, filed 5 Nov 2026.